26/02/2026 22:12
|
Medical, Health & Aged Care
* Total global revenues of $1.5 billion and $5.3 billion for the fourth quarter and full year, increases of 33% and 40% from the prior-year periods
* Global BRUKINSA (zanubrutinib) revenues of...